Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Greenwich Lifesciences

GLSI

15.0800.33% ( +0.050 )

Trading: Sep 10, 14:15:39 (EDT)

OverviewOverview NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Greenwich LifeSciences (NASDAQ:GLSI) Posts Quarterly Earnings Results
Market Beat·Aug 11 at 10:41 PM
GLSI+0.40%BCS-1.29%
Greenwich LifeSciences extends insider lock-up to Jan. 31, 2027
PUBT·Aug 10 at 10:01 AM
GLSI+0.40%
Top Executive Doubles Down on Greenwich LifeSciences With Fresh Insider Buy
Tip Ranks·Jul 31 at 02:05 AM
GLSI+0.40%
Greenwich LifeSciences (NASDAQ:GLSI) CEO Snehal Patel Purchases 1,500 Shares
Market Beat·Jul 29 at 11:07 AM
- Greenwich LifeSciences CEO Snehal Patel purchased 1,500 shares of company stock at an average cost of $13.62 per share, totaling $20,430.00. - This transaction followed previous purchases made on July 23rd and July 24th, increasing his total holdings to 5,609,202 shares valued at $76,397,331.24. - The acquisition was officially disclosed in a regulatory filing with the Securities & Exchange Commission.
GLSI+0.40%BAC-0.49%
Greenwich Lifesciences CEO and CFO Snehal Patel acquires $20,430 of common shares
PUBT·Jul 29 at 10:08 AM
GLSI+0.40%
Greenwich LifeSciences CEO, CFO Snehal Patel acquires common shares worth $47,005
PUBT·Jul 27 at 10:15 AM
GLSI+0.40%
Greenwich LifeSciences wins UK regulatory clearance to expand FLAMINGO-01 trial
PUBT·Jul 22 at 10:00 AM
GLSI+0.40%
HC Wainwright Forecasts Strong Price Appreciation for Greenwich LifeSciences (NASDAQ:GLSI) Stock
Market Beat·Jul 21 at 05:18 PM
GLSI+0.40%
Greenwich LifeSciences flags release with FLAMINGO-01 clinical update
PUBT·Jul 20 at 10:03 AM
GLSI+0.40%